Axsome Therapeutics Inc (AXSM)
EBITDA Margin
-22.68%
TTM · Period ending:
AXSM EBITDA Margin
Latest reported-22.68%period ending
Latest reported-22.68%period ending
AXSM TTM EBITDA Margin (-1601.97% → -22.68%)
TTM ebitda margin
High-resolution chart · PNG
AXSM ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -22.6805% | |
| -24.2774% | |
| -25.9673% | |
| -37.7116% | |
| -46.1638% | |
| -60.6282% | |
| -70.679% | |
| -88.2221% | |
| -102.3737% | |
| -113.641% | |
| -82.8599% | |
| -83.0577% | |
| -90.7741% | |
| -97.263% | |
| -348.2076% | |
| -579.1117% | |
| -1,601.9693% |